Epidermolysis Bullosa
B-VEC FDA Label Expansion for DEB: What It Means for Patients and CliniciansÂ
In May 2023, the FDA approved beremagene geperpavec (B-VEC, Vyjuvek®),
September 17, 2025
In May 2023, the FDA approved beremagene geperpavec (B-VEC, Vyjuvek®),
World Atopic Eczema Day and National Atopic Eczema Week shine
As dermatology and aesthetic professionals, you know that healthy skin
Messenger RNA (mRNA) technology gained prominence during the COVID-19 pandemic,
In today’s hyperconnected world, social media isn’t just a personal
Recent research has revealed that hidradenitis suppurativa (HS) is not
For many dermatological treatments, consistent application, lifestyle modifications, and patient
The dermatology world converged in Miami Beach from Feb. 6-8,
The South Beach Symposium (SBS) and Masters of Pediatric Dermatology
As we enter into the new year, it’s an ideal
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
